NP91617b Cladribine (Mavenclad®)
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £3M
- Sector
- HEALTH
- Published
- 08 Jul 2022
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
All entities constituted pursuant to NHS (Scotland) Act 1978, any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014 and HSC Trusts in Northern Ireland
1 buyer
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Merck Serono Middlesex
Description
The Framework Agreement is for the supply of Cladribine (Mavenclad®) to NHS Scotland.
Total Quantity or Scope
The framework agreement is awarded for the supply of Cladribine (Mavenclad®).
Award Detail
| 1 | Merck Serono (Middlesex)
|
CPV Codes
- 33600000 - Pharmaceutical products
Legal Justification
This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.I.7 and Section V2.4 covers the six(6) month modification period of the framework agreement. (SC Ref:699218)
Reference
- ocds-h6vhtk-02f99c
- FTS 018774-2022